Kwon E - Search Results

1

Outcomes for Patients with Clinical Lymphadenopathy Treated with Radical Prostatectomy.

Moschini M, Briganti A, Murphy CR, Bianchi M, Gandaglia G, Montorsi F, Quevedo JF, Carlson R, Kwon E, Karnes RJ. Moschini M, et al. Among authors: kwon e. Eur Urol. 2016 Feb;69(2):193-6. doi: 10.1016/j.eururo.2015.07.047. Epub 2015 Aug 8. Eur Urol. 2016. PMID: 26264160

2

Prediction of progression after radical nephrectomy for patients with clear cell renal cell carcinoma: a stratification tool for prospective clinical trials.

Leibovich BC, Blute ML, Cheville JC, Lohse CM, Frank I, Kwon ED, Weaver AL, Parker AS, Zincke H. Leibovich BC, et al. Cancer. 2003 Apr 1;97(7):1663-71. doi: 10.1002/cncr.11234. Cancer. 2003. PMID: 12655523 Free article.

3

pT2 classification for renal cell carcinoma. Can its accuracy be improved?

Frank I, Blute ML, Leibovich BC, Cheville JC, Lohse CM, Kwon ED, Zincke H. Frank I, et al. J Urol. 2005 Feb;173(2):380-4. doi: 10.1097/01.ju.0000149937.75566.ac. J Urol. 2005. PMID: 15643175

4

Cancer specific survival for patients with pT3 renal cell carcinoma-can the 2002 primary tumor classification be improved?

Leibovich BC, Cheville JC, Lohse CM, Zincke H, Kwon ED, Frank I, Thompson RH, Blute ML. Leibovich BC, et al. J Urol. 2005 Mar;173(3):716-9. doi: 10.1097/01.ju.0000151830.27750.d2. J Urol. 2005. PMID: 15711250

5

Should direct ipsilateral adrenal invasion from renal cell carcinoma be classified as pT3a?

Thompson RH, Leibovich BC, Cheville JC, Lohse CM, Frank I, Kwon ED, Zincke H, Blute ML. Thompson RH, et al. J Urol. 2005 Mar;173(3):918-21. doi: 10.1097/01.ju.0000153419.98715.24. J Urol. 2005. PMID: 15711327

6

Comparison of presentation and outcome for patients 18 to 40 and 60 to 70 years old with solid renal masses.

Gillett MD, Cheville JC, Karnes RJ, Lohse CM, Kwon ED, Leibovich BC, Zincke H, Blute ML. Gillett MD, et al. J Urol. 2005 Jun;173(6):1893-6. doi: 10.1097/01.ju.0000158157.57981.80. J Urol. 2005. PMID: 15879770

7

Is renal sinus fat invasion the same as perinephric fat invasion for pT3a renal cell carcinoma?

Thompson RH, Leibovich BC, Cheville JC, Webster WS, Lohse CM, Kwon ED, Frank I, Zincke H, Blute ML. Thompson RH, et al. J Urol. 2005 Oct;174(4 Pt 1):1218-21. doi: 10.1097/01.ju.0000173942.19990.40. J Urol. 2005. PMID: 16145373

8

A scoring algorithm to predict survival for patients with metastatic clear cell renal cell carcinoma: a stratification tool for prospective clinical trials.

Leibovich BC, Cheville JC, Lohse CM, Zincke H, Frank I, Kwon ED, Merchan JR, Blute ML. Leibovich BC, et al. J Urol. 2005 Nov;174(5):1759-63; discussion 1763. doi: 10.1097/01.ju.0000177487.64651.3a. J Urol. 2005. PMID: 16217278

9

Immunotherapy for prostate cancer.

Karnes RJ, Whelan CM, Kwon ED. Karnes RJ, et al. Curr Pharm Des. 2006;12(7):807-17. doi: 10.2174/138161206776056001. Curr Pharm Des. 2006. PMID: 16515497 Review.

10

Outcomes of Gleason score 10 prostate carcinoma treated by radical prostatectomy.

Inman BA, DiMarco DS, Slezak JM, Sebo TJ, Kwon ED, Leibovich BC, Blute ML, Zincke H. Inman BA, et al. Urology. 2006 Sep;68(3):604-8. doi: 10.1016/j.urology.2006.03.041. Epub 2006 Sep 18. Urology. 2006. PMID: 16979719

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,659 results

Search Page

Filters